Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.52 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PREP | P48147 | 2/20 | 0.38 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4039490 | 0.93 | CTSK (0.54) | CTSKCTSSALDH1A1PREPFAP | |
| SCHEMBL4043775 | 0.92 | CTSK (0.50) | CTSKCTSSALDH1A1KMT2APREP | |
| SCHEMBL4041463 | 0.92 | CTSK (0.43) | CTSKALDH1A1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL4041900 | 0.92 | CTSK (0.54) | CTSKCTSSALDH1A1PREPFAP | |
| SCHEMBL4042674 | 0.92 | CTSK (0.51) | CTSKCTSSALDH1A1PREPFAP | |
| SCHEMBL4045315 | 0.91 | CTSK (0.53) | CTSKCTSSALDH1A1RAB9APREP | |
| SCHEMBL4040987 | 0.91 | CTSK (0.65) | CTSKCTSSALDH1A1RAB9APREP | |
| SCHEMBL4046916 | 0.90 | CTSK (0.65) | CTSKCTSSALDH1A1CHRNB2CHRNA7 | |
| SCHEMBL4037336 | 0.90 | CTSK (0.56) | CTSKCTSSALDH1A1PREPFAP | |
| SCHEMBL4037456 | 0.90 | CTSK (0.51) | CTSKCTSSALDH1A1CHRNB2CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | claimed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | claimed |
| WO-2009055128-A2 | COMPOSITIONS FOR CHEMICAL AND BIOLOGICAL DEFENSE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-04-30 | — | — | WO | disclosed |
| WO-2009026348-A2 | ANTIFUNGAL AGENTS FROM A STREPTOMYCETE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-02-26 | — | — | WO | disclosed |
| WO-2007092029-A2 | CATALYTIC NANOPARTICLES FOR NERVE-AGENT DESTRUCTION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-08-16 | — | — | WO | disclosed |
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |